Press Releases May 14, 2026 07:00 AM

Barrick Announces Election of Directors

Barrick Mining Corporation Elects Board of Directors and Approves Key Governance Resolutions at 2026 Annual Meeting

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
B

Barrick Mining Corporation announced the election of its board of directors, appointment of auditors, and approval of executive compensation at its 2026 Annual Meeting. The company confirmed strong shareholder support for its governance proposals, reinforcing stable management and oversight as it continues operations across 17 countries.

Barrick Announces Election of Directors
B
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • All nominated directors were elected with majority shareholder approval, reflecting confidence in current leadership.
  • Appointment of auditors was approved with over 93% votes in favor, ensuring ongoing financial oversight.
  • Advisory resolution on executive compensation passed with approximately 77% support, indicating moderate shareholder endorsement for executive pay.
  • The company operates large-scale gold and copper mining assets across multiple global regions, including being the largest gold producer in the US.

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B)(TSX:ABX) announced that the nominees listed in the Information Circular for the 2026 Annual Meeting of Shareholders were elected as directors of Barrick.

Detailed results of the vote for the election of directors, the appointment of auditors, and the advisory resolution on executive compensation, based on final calculations, are set out below.

Voting results for the election of each of the directors are as follows:

NomineeVotes For% ForVotes Withheld% WithheldHelen Cai940,558,96287.49%134,528,20712.51%Brian L. Greenspun998,737,36992.9%76,349,8007.1%J. Brett Harvey1,012,627,30494.19%62,459,8655.81%Mark F. Hill1,066,692,11899.22%8,395,0520.78%Anne N. Kabagambe1,054,516,93398.09%20,570,2361.91%Robert A.P. Samek1,071,095,83999.63%3,991,3300.37%Loreto Silva1,044,181,20597.13%30,905,9642.87%John L. Thornton871,938,94781.1%203,148,22318.9%Pekka J. Vauramo996,034,93592.65%79,052,2347.35% 

Voting results for the resolution approving the appointment of the auditor are as follows:

Votes For% ForVotes Withheld% Withheld1,098,358,92193.27%79,288,9566.73% 

Voting results for the advisory resolution on executive compensation are as follows:

Votes For% ForVotes Against% Withheld824,474,08276.66%251,090,33723.34% 

About Barrick Mining Corporation

Barrick is a leading global mining, exploration and development company. With one of the largest portfolios of world-class and long-life gold and copper assets in the industry, Barrick’s operations and projects span 17 countries and five continents. Barrick is also the largest gold producer in the United States. We create real, long-term value for all stakeholders through responsible mining, strong partnerships and a disciplined approach to growth. Barrick shares trade on the New York Stock Exchange under the symbol ‘B’ and on the Toronto Stock Exchange under the symbol ‘ABX’.

Investor Relations Contact

Barrick Mining Corporation
Cleve Rueckert, +1 775 397 5443
cleveland.rueckert@barrick.com

Media Contact

Brunswick Group
Carole Cable, +44 (0) 20 7404 5959
barrick@brunswickgroup.com


Risks

  • Potential shareholder dissent indicated by withheld votes in director elections could suggest some governance concerns impacting investor relations.
  • The advisory vote on executive compensation received less than unanimous support, which might lead to reputational risks related to pay practices.
  • Operational challenges in multiple countries, including geopolitical risks and regulatory changes, may impact mining operations and profitability.

More from Press Releases

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026